A detailed history of Amf Tjanstepension Ab transactions in Exact Sciences Corp stock. As of the latest transaction made, Amf Tjanstepension Ab holds 55,916 shares of EXAS stock, worth $2.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
55,916
Previous 10,624 426.32%
Holding current value
$2.55 Million
Previous $723,000 334.44%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$49.33 - $71.97 $2.23 Million - $3.26 Million
45,292 Added 426.32%
55,916 $3.14 Million
Q3 2024

Oct 03, 2024

BUY
$42.43 - $70.83 $450,776 - $752,497
10,624 New
10,624 $723,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.07B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Amf Tjanstepension Ab Portfolio

Follow Amf Tjanstepension Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amf Tjanstepension Ab, based on Form 13F filings with the SEC.

News

Stay updated on Amf Tjanstepension Ab with notifications on news.